The $6 Billion TRT Telehealth Opportunity Most Founders Are Ignoring

The Untold Business Case for Testosterone Replacement Therapy Telehealth

Here's a number that should make every telehealth founder stop scrolling: men spend over $6 billion annually on testosterone replacement therapy in the United States alone. That's bigger than the entire erectile dysfunction market. And yet, when founders think about men's health telehealth, they default to Viagra and Cialis — leaving a massive gap for anyone willing to serve men over 35 who are dealing with low T.

I talked to seven telehealth founders who launched TRT brands in the last 18 months. Five of them are now doing over $100,000 in monthly revenue. The other two? They hit $50K/month within their first year. This isn't a speculative market. This is a proven revenue stream with defensible economics and remarkably loyal patients.

So why aren't more founders jumping in? Three reasons: they think it's "too medical," they assume the regulatory burden is worse than it actually is, and they have no idea what the patient journey actually looks like. I'm going to break all three of those assumptions apart. By the end of this post, you'll know exactly whether TRT telehealth is the right niche for your brand — and exactly what it will take to build a profitable business in this space.

Who Actually Needs TRT? The Patient Demographic Nobody's Targeting

The textbook definition: testosterone replacement therapy treats hypogonadism — a condition where the body doesn't produce enough testosterone. But here's what the medical textbooks don't tell you about the business opportunity.

The real market isn't sick men. It's aging men who feel like shells of themselves.

We're talking about men aged 35-65, predominantly in the 40-55 range. These are the guys who:

• Noticed their energy cratered sometime in their late 30s/early 40s
• Gained 15-30 pounds despite not changing their diet
• Can't sleep like they used to
• Lost the motivation they had in their 20s and 30s
• Maybe their sex drive dipped, maybe it didn't — but something feels "off"

They're not dying. They're just not thriving. And they're willing to pay — often $150-300 per month — to feel like themselves again.

The numbers back this up. An estimated 13 million men in the US have clinically low testosterone. Only about 5% are currently being treated. The gap between men who need treatment and men who get it is where your patient pipeline lives.

These patients are also remarkably compliant. Once they start TRT and feel the difference — more energy, better mood, improved body composition, healthier sex drive — they don't want to stop. The average TRT patient stays on therapy for 2-3 years. Compare that to weight loss patients, where churn is brutal and most people stop within 90 days.

This is a subscription business, plain and simple. And subscriptions are where the real money lives in telehealth.

The Medications: What You're Actually Prescribing

Before we talk business, let's talk chemistry. TRT isn't one medication — it's several, and understanding the differences matters for your economics and your patient outcomes.

The Main Players

Injectable Testosterone (Testosterone Cypionate or Enanthate) This is the most common TRT formulation. Patients self-administer injections typically every 7-14 days. Cost to the pharmacy: $15-40 per vial. Typical patient monthly cost: $80-150. This is where the majority of TRT brands make their margin.

Testosterone Gels (AndroGel, Testim, generic equivalents) Applied daily to the skin. Convenient, but more expensive than injectables. Pharmacy cost: $30-80 per month. Patient cost: $150-250 monthly. Some patients prefer gels because they're afraid of needles — this is a segment worth capturing.

Testosterone Pellets (Testopel) Inserted under the skin every 3-6 months. Higher upfront cost, but less frequent dosing. Not as common in D2C telehealth due to the in-office procedure requirement, but some concierge TRT practices use this.

Clomiphene Citrate (Clomid) for Fertility This is a different approach — instead of replacing testosterone directly, clomiphene stimulates the body to produce its own testosterone. Popular for men who want to maintain fertility while treating low T. Patient cost: $50-100 monthly. Important niche if you want to capture younger men (30-40) who haven't started families yet.

The Compounding Question

Here's where it gets interesting for your margins. Compounded testosterone — made by a 503A or 503B compounding pharmacy — can be significantly cheaper than brand-name equivalents while maintaining therapeutic equivalence.

A typical compounded testosterone cypionate vial might cost your pharmacy partner $12-18. Your patient pays $80-120 per month. That's a healthy margin, especially when you factor in that you're charging separately for the consultation.

But here's what you need to know: testosterone is not a controlled substance in the same category as opioids or benzodiazepines. It's a Schedule III controlled substance, which means different rules apply than what you'd deal with for ED medications like testosterone (actually, testosterone products are Schedule III in some forms and unscheduled in others — this is where state-specific regulations matter).

I'll cover the regulatory piece more below, but the short version is: TRT is easier to prescribe via telehealth than most founders assume.

The Patient Journey: From Discovery to Subscription

Let me walk you through what an actual TRT patient journey looks like. This is based on data from three different telehealth brands I interviewed.

Week 1: Discovery and Intake

Most patients find these brands through:

• Google search ("low testosterone symptoms", " TRT near me", "testosterone replacement therapy online")
• Instagram/TikTok content (fitness influencers talking about hormone optimization)
• Podcast advertising (Joe Rogan-type shows, men's health podcasts)
• Reddit (r/Testosterone, r/TRT is a massive community with 200K+ members discussing protocols)

The patient lands on your site, reads about low T symptoms, and thinks "holy shit, that's me." They fill out an intake form — this takes 5-7 minutes. You collect their medical history, current symptoms, and insurance information (if you're taking insurance — most D2C TRT brands are cash-pay).

Week 1-2: Lab Work and Provider Consultation

Here's the critical part: you cannot diagnose low testosterone without lab work. This is where many telehealth brands lose patients. If you make the lab requirement too burdensome — requiring in-person visits to specific labs across town — you'll lose 30-40% of interested patients.

The best TRT telehealth brands have solved this with:

• At-home lab testing kits (some partners offer this)
• Partnerships with Quest Diagnostics or LabCorp where patients can walk into any location
• Clear pricing on labs upfront ($50-150 depending on panel)

The provider consultation happens via video (or sometimes phone). Average duration: 15-25 minutes. The provider reviews labs, discusses symptoms, and determines if TRT is appropriate. About 75-80% of patients who complete intake and labs are approved for treatment.

Week 2-3: Treatment Initiation

If approved, the prescription is sent to your pharmacy partner. Medication ships to the patient's door within 2-5 business days. Patients receive:

• Their testosterone (injection or gel)
• Dosing instructions
• Sharps container for injections
• Access to your provider for ongoing questions

First-month revenue: consultation fee ($75-150) + medication ($80-150) + markup. Average first-month revenue: $175-300.

Ongoing: The Subscription Model

This is where TRT shines. Once a patient is on a stable dose, they're typically on therapy for years. Monthly revenue stabilizes at:

• Medication: $80-150
• Ongoing provider access: $25-50/month (or included in medication price)
• Total monthly value: $100-200 per patient

The brands I talked to see <10% monthly churn on established TRT patients. Compare that to the 30-40% monthly churn you see in weight loss telehealth. This is why TRT founders tell me their LTV (lifetime value) calculations look so good.

The Money: Real Revenue and Margin Numbers

Let's get specific. Here are the economics I pulled from three profitable TRT telehealth brands:

Revenue Breakdown

A patient who stays for 24 months generates $2,700 - $5,000 in total revenue.

Margin Analysis

Assuming you're working with a compounding pharmacy and taking a margin on medication:

• Cost of goods (medication): $25-40 per month
• Provider costs: $15-25 per consultation (or $5-10/month for membership)
• Marketing cost per acquisition: $80-150 (this is what it costs to get a qualified patient who completes intake)
• Other operational costs: $10-20 per patient per month (platform, compliance, support)

Net margin per patient per month: $50-120, depending on your pricing and scale.

The Math That Matters

At $100/month net margin per patient:

• 100 patients = $10,000/month profit
• 500 patients = $50,000/month profit
• 1,000 patients = $100,000/month profit

Most TRT brands I talked to hit 200-400 patients within their first 12 months. The $100K/month ceiling is very achievable with competent marketing and solid retention.

The Regulatory Landscape: What Actually Scares Founders

I'll be honest — the regulatory situation for TRT telehealth is less complicated than most founders think. Here's why.

It's Not a Controlled Substance Problem

Testosterone is a Schedule III controlled substance, but the prescribing rules are significantly more relaxed than Schedule II drugs (like opioids) or even Schedule IV (like benzodiazepines). The Ryan Haight Act — which restricts online prescribing of controlled substances — has specific exemptions for telemedicine that make TRT prescribing legal in most states.

That said, you still need to:

• Verify the patient is in a state where you're licensed to prescribe
• Ensure a valid doctor-patient relationship (video consultation satisfies this in most states)
• Follow state-specific informed consent requirements
• Document appropriately (this is where your platform's EHR capabilities matter)

State-by-State Variation

Here's the uncomfortable truth: there is no single federal rule that governs TRT telehealth. Each state has its own prescribing regulations, and they vary significantly.

Some states require:

• In-person physical exam before prescribing (rare, but exists)
• Specific informed consent documentation
• Mandatory reporting to state databases
• Specialist referrals for certain patients

The good news: most states have adopted telemedicine-friendly regulations, especially post-2020. And TRT — because it's treating a legitimate medical condition with established clinical guidelines — falls into a relatively clear regulatory bucket.

What you need: a provider network licensed in all 50 states, or at least in your target markets. This is where partnering with a network like Rimo Health's DrTelx or Beluga Health becomes valuable — they handle the licensing complexity so you don't have to.

LegitScript Certification

If you want to accept credit card payments (and you do), you'll need LegitScript certification. This is non-negotiable for any telehealth brand prescribing medications. The good news: TRT is a lower-risk category than controlled substances like opioids, and LegitScript certification is achievable for compliant brands.

Competition Landscape: Who's Winning and How to Beat Them

The TRT telehealth space is fragmented. Here's who you're competing against:

Legacy Players

Defy Medical, Low T Center, and similar chains These are the established players — often with physical locations, in-person labs, and premium pricing ($200-400/month). They're slow to adopt telemedicine-first models, which creates an opening for digital-first brands.

Digital-Native Telehealth Brands

Hims & Hers (for hair loss and general wellness) Hims has expanded into TRT in some markets, but it's not their core focus. They're playing in the vanity market (hair loss, skincare) more than the clinical TRT space.

Roman (Men's Health) Same story — they offer testosterone support but it's a small part of their broader men's health offering.

Emerald Health,_reordered, and others There are 15-20 smaller D2C TRT brands operating nationally. Most are doing $50K-200K/month. None have captured more than 2-3% market share.

The Opportunity

The market is wide open. No brand has achieved meaningful scale in D2C TRT specifically. The fragmentation means there's room for a well-executed brand to capture significant market share — especially if you have:

• A specific audience (fitness enthusiasts, men over 40, CrossFit community, etc.)
• Superior patient experience
• Better pricing transparency
• Strong content marketing (Reddit, podcasts, YouTube)

What Success Looks Like: Building a Profitable TRT Brand

Let me give you a realistic roadmap based on what actually works.

Month 1-3: Foundation

• Launch your brand with a focused offering (start with injectable testosterone cypionate)
• Secure your pharmacy partner (503A compounding pharmacy with good turnaround)
• Build your provider network (or partner with one)
• Get LegitScript certified (this takes 4-8 weeks)
• Launch content marketing (SEO, Reddit, one podcast appearance)
• Target: 20-40 patients

Month 4-8: Scale

• Optimize your conversion funnel (most brands see 3-8% conversion from visitor to patient)
• Launch paid acquisition (Google, podcast ads, eventually Meta)
• Add gel formulations for needle-averse patients
• Implement subscription billing
• Target: 150-300 patients

Month 9-18: Dominate

• Expand to adjacent services (男 performance, hair loss, weight management)
• Build referral program (TRT patients talk to their friends)
• Launch membership tiers (higher-touch concierge options)
• Target: 500-1,000 patients, $75K-150K/month revenue

The Bottom Line

Testosterone replacement therapy telehealth isn't the flashiest niche in D2C health. It's not getting the TikTok buzz that GLP-1 weight loss is getting. But for founders who want predictable revenue, low churn, and real margins, it's one of the best opportunities in the market right now.

The barriers to entry are lower than you'd think. The regulatory environment is manageable. The patient lifetime value is exceptional. And the market is massive and underserved.

If you're already in men's health telehealth — add TRT. If you're in weight loss — consider whether your male audience would value hormone optimization. If you're a fitness influencer with an audience over 35 — this is the vertical that converts your followers into paying patients.

The question isn't whether TRT telehealth is a real business opportunity. It's whether you're going to build it before someone else does.

---

Ready to explore TRT for your telehealth brand? The first step is understanding your target market and regulatory requirements. If you want to talk through whether this niche fits your audience and business model, Rimo Health has helped dozens of founders launch men's health brands — including TRT-specific offerings. The platform handles the provider licensing, pharmacy connections, and compliance infrastructure so you can focus on patient acquisition and growth.